A detailed history of Aqr Capital Management LLC transactions in Liquidia Corp stock. As of the latest transaction made, Aqr Capital Management LLC holds 21,597 shares of LQDA stock, worth $232,167. This represents 0.0% of its overall portfolio holdings.

Number of Shares
21,597
Previous 23,757 9.09%
Holding current value
$232,167
Previous $285,000 24.56%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$8.9 - $14.11 $19,224 - $30,477
-2,160 Reduced 9.09%
21,597 $215,000
Q2 2024

Aug 14, 2024

SELL
$11.96 - $15.71 $27,304 - $35,865
-2,283 Reduced 8.77%
23,757 $285,000
Q1 2024

May 15, 2024

SELL
$11.35 - $16.73 $57,975 - $85,456
-5,108 Reduced 16.4%
26,040 $384,000
Q4 2023

Feb 14, 2024

SELL
$5.77 - $12.19 $8,274 - $17,480
-1,434 Reduced 4.4%
31,148 $374,000
Q3 2023

Nov 14, 2023

SELL
$6.27 - $8.15 $2,112 - $2,746
-337 Reduced 1.02%
32,582 $206,000
Q2 2023

Aug 14, 2023

SELL
$6.63 - $9.9 $9,434 - $14,087
-1,423 Reduced 4.14%
32,919 $258,000
Q1 2023

May 15, 2023

SELL
$5.72 - $7.91 $15,438 - $21,349
-2,699 Reduced 7.29%
34,342 $237,000
Q4 2022

Feb 14, 2023

SELL
$4.68 - $6.54 $20,657 - $28,867
-4,414 Reduced 10.65%
37,041 $235,000
Q3 2022

Nov 14, 2022

BUY
$3.73 - $8.39 $154,627 - $347,807
41,455 New
41,455 $226,000
Q1 2021

May 17, 2021

SELL
$2.42 - $3.6 $219,738 - $326,883
-90,801 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$2.6 - $5.79 $188,193 - $419,091
72,382 Added 392.97%
90,801 $268,000
Q3 2020

Nov 16, 2020

BUY
$4.34 - $8.28 $79,938 - $152,509
18,419 New
18,419 $91,000

Others Institutions Holding LQDA

About Liquidia Corp


  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $692M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.